Regeneron and Roche Await Data On Potential COVID-19 Blockbuster

Early Signs Of Efficacy Expected In September

 
• By Andrew McConaghie
Antibodies
Monoclonal antibody therapies could mimic the body's own defenses against SARS-CoV-2 virus - but act faster, and help block infection

More from Business

More from Scrip